Effects of hyperbaric oxygen on expression of transforming growth factor-beta 1 in serum and kidney in diabetes rats
Fang Liu,Jing-hua Zhou,Pei-ling Guan,Ming-shu Peng,Jie Zhang,Ci-sheng Zhong,Jia Shi,Jian-feng Xu,Gui-qiang Shao,Guo-qiang Bu,Qing-gu Yao
DOI: https://doi.org/10.3321/j.issn:1673-8225.2005.39.037
2005-01-01
Abstract:Aim: To investigate the effects of hyperbaric oxygen therapy (HBOT) on the serum and expression of transforming growth factor-beta 1(TGF-β1) with ultrastructure of kidney in diabetic rats. Methods: 1 The experime nt was conducted at the Animal Ward, Department of Pathology, Shanghai Municipal Fifth People's Hospital and Electron-microscope Room, Shanghai Medical University, Fudan University from October 2002 to March 2003. Ninety male healthy SD rats aged 2 months were selected. Twenty normal rats were retained randomly. Based on 55 mg/kg, other fasting rats were treated with 10 g/L streptozotocin solution with intraperitoneal injection as diabetes model overnight. Among the diabetes rats, there were 63 diabetic nephropathy rats with abnormal ultrastructure after 2-months progress observed with electron microscope. They were assigned randomly into 3 groups: model group (n=32), hyperbaric oxygen treatment group (n=31) and control group (n=20). The 20 rats in the control group were only treated with saline at the same volume with intraperitoneal injection, without intervention. The 32 rats in the model group were treated with regular insulin and deposulin once in the other morning to control glucose from 8 to 13 mmol/ L. The 31 cats in the hyperbaric oxygen treatment group were equally treated with insulin and deposulin to control glucose, entering animal chamber at the pressure of 0.15 MPa, sucking pure oxygen at the concentration of 95% for 1 hour, lasing for 20 days. 2 After being treated with hyperbaric oxygen for 10 and 20 days, respectively, femoral arterial blood and kidney were gained in batch, and then the rats were killed. Caudal vein glucose and body mass were detected with swift glucose apparatus. The femoral arterial blood was gained to detect the level of TGF-β1 of serum in rats of every group. At the same time, the pathological change of kidney was observed using HE staining and electron-microscope, and the TGF-β1 immunostaining in kidney was observed using DAB two-step method. 3 Comparison among groups was performed with t-test. Results: 1 During intervention in batch, 1 rat d ied in the hyperbaric oxygen treatment group, and 2 rats died in the model group. The level of TGF-β1 of serum was detected in 20 rats of control group, 30 rats in hyperbaric oxygen treatment group and 30 rats in model group. After being treated with hyperbaric oxygen for 10 days, 6 rats in the control group, 7 rats in the model group and 7 rats in the hyperbaric oxygen treatment group were killed. After being treated with hyperbaric oxygen for 20 days, 6 rats in the control group, 8 rats in the model group and 8 rats in the hyperbaric oxygen treatment group were killed. Corresponding indexes were detected, respectively. 2 Before treatment, the level of TGF-β1 of serum was significantly higher than that in the control group in diabetes rats (P < 0.05). Pathology mainly showed that glass-like substrate in renal glomerulus was ameliorated, sclerosis and the vessel reduced. Electron microscope observation indicated that vessel loop foot process in glomerular in the model group reduced, combined, arranged disorder, and the interstitial and matrix in the theca cells was deposition and fibrosis. 3 After being treated for 10 days, the level of TGF-β 1 of serum in rats of hyperbaric oxygen treatment group was lower significantly than that in the model group (P < 0.05). The ultrastructure of kidney was improved primarily, but the changes were insignificantly. 4 After being treated for 20 days, the abnormal pathological glomerular in hyperbaric oxygen treatment group lightened, and the ultrastructure improved significantly as compared with the diabetes group, but it was similar to the control group; The level of TGF-β1 of serum was lower significantly than that in the model group (P < 0.01), while the difference was insignificant as compared with control group (P > 0.05). Immunohistochemical method showed that TGF-β1 staining in the interstitial of glomerulus and renal tubule decreased significantly. Conclusion: The hyperbaric oxygen therapy can improve the kidney lesion in diabetes rats, and its mechanism can be related to inhibition of circulating TGF-β1 and expression in kidney.